PARP1 and cancer: Overall, developing PARPis brings new hope to cancer treatment, especially for BRCA mutation-positive patients, as improving the selectivity of PARP-1, enhancing the inhibitory capability of PARPis, and adopting strategies to reduce drug toxicity and side effects are all ideas and directions for developing PARPis.